Transport of thyroid hormones in serum and cerebrospinal fluid.

PubWeight™: 1.01‹?› | Rank: Top 15%

🔗 View Article (PMID 4206491)

Published in J Clin Endocrinol Metab on September 01, 1973

Authors

G A Hagen, W J Elliott

Articles citing this

Chronic lead exposure alters transthyretin concentration in rat cerebrospinal fluid: the role of the choroid plexus. Toxicol Appl Pharmacol (1996) 1.81

The transthyretin amyloidoses: from delineating the molecular mechanism of aggregation linked to pathology to a regulatory-agency-approved drug. J Mol Biol (2012) 1.70

Inhibition by lead of production and secretion of transthyretin in the choroid plexus: its relation to thyroxine transport at blood-CSF barrier. Toxicol Appl Pharmacol (1999) 1.10

Transthyretin, thyroxine, and retinol-binding protein in human cerebrospinal fluid: effect of lead exposure. Toxicol Sci (2001) 1.01

Brain meets body: the blood-brain barrier as an endocrine interface. Endocrinology (2012) 0.98

Influx of thyroid hormones into rat liver in vivo. Differential availability of thyroxine and triiodothyronine bound by plasma proteins. J Clin Invest (1980) 0.87

Iodine atoms: a new molecular feature for the design of potent transthyretin fibrillogenesis inhibitors. PLoS One (2009) 0.87

Induction of type 2 iodothyronine deiodinase in the mediobasal hypothalamus by bacterial lipopolysaccharide: role of corticosterone. Endocrinology (2008) 0.85

Transport of L-[125I]thyroxine by in situ perfused ovine choroid plexus: inhibition by lead exposure. J Toxicol Environ Health A (2003) 0.84

Why is Leu55-->Pro55 transthyretin variant the most amyloidogenic: insights from molecular dynamics simulations of transthyretin monomers. Protein Sci (2003) 0.83

Current and future treatment of amyloid diseases. J Intern Med (2016) 0.83

Delayed development of specific thyroid hormone-regulated events in transthyretin null mice. Am J Physiol Endocrinol Metab (2012) 0.82

From molecular variant to disease: initial steps in evaluating the association of transthyretin M119 with disease. Am J Hum Genet (1992) 0.75

BDE-99 impairs differentiation of human and mouse NPCs into the oligodendroglial lineage by species-specific modes of action. Sci Rep (2017) 0.75

Peptide probes detect misfolded transthyretin oligomers in plasma of hereditary amyloidosis patients. Sci Transl Med (2017) 0.75

Articles by these authors

Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group. Am J Kidney Dis (2000) 3.37

Ear lobe crease and coronary artery disease. 1,000 patients and review of the literature. Am J Med (1983) 1.01

Hyponatremia due to sulfonylurea compounds. J Clin Endocrinol Metab (1970) 0.99

Treatment of thyrotoxicosis with 131-I and post-therapy hypothryoidism. Med Clin North Am (1968) 0.93

Dopamine and dopamine receptor agonists in cardiovascular therapy. Crit Care Med (1990) 0.93

Comparison of high and low dosage levels of 131-I in the treatment of thyrotoxicosis. N Engl J Med (1967) 0.91

Low-dosage 131-I therapy of thyrotoxicosis (diffuse goiters). A five-year follow-up study. N Engl J Med (1974) 0.91

Drug-induced hyponatraemia in psychogenic polydipsia. Postgrad Med J (1976) 0.90

Peroxidase deficiency in familial goiter with iodide organification defect. N Engl J Med (1971) 0.85

The relative efficacies of 7S and 19S Forssman antibody in producing lesions in the guinea pig. Proc Soc Exp Biol Med (1972) 0.84

Fenoldopam, but not nitroprusside, improves renal function in severely hypertensive patients with impaired renal function. Am J Med (1993) 0.84

Comparison of effects of controlled onset extended release verapamil at bedtime and nifedipine gastrointestinal therapeutic system on arising on early morning blood pressure, heart rate, and the heart rate-blood pressure product. Am J Cardiol (1998) 0.84

The metabolic transformations of columbinic acid and the effect of topical application of the major metabolites on rat skin. J Biol Chem (1985) 0.82

Co-existent diabetes mellitus and diabetes insipidus, a familial disease. J Clin Endocrinol Metab (1975) 0.82

An increase in the number of deaths in the United States in the first week of the month. N Engl J Med (1999) 0.82

Physiologic effects of columbinic acid and its metabolites on rat skin. Biochim Biophys Acta (1985) 0.82

Thyroid hormone formation catalyzed by human thyroid peroxidase: a new and physiological measurement of thyroid peroxidase. J Lab Clin Med (1982) 0.80

Brain and cerebrospinal fluid permeability to intravenous thyroid hormones. Endocrinology (1974) 0.80

A unique cardiac cytosolic acyltransferase with preferential selectivity for fatty acids that form cyclooxygenase/lipoxygenase metabolites and reverse essential fatty acid deficiency. Biochim Biophys Acta (1985) 0.80

ALLHAT: the largest and most important clinical trial in hypertension ever done in the USA. Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial. Am J Hypertens (1996) 0.80

Selected factors that influence responses to antihypertensives. Choosing therapy for the uncomplicated patient. Arch Fam Med (1994) 0.79

Comparison of nifedipine alone and with diltiazem or verapamil in hypertension. Hypertension (1996) 0.78

Ectopic ACTH syndrome due to salivary gland adenoid cystic carcinoma. Arch Intern Med (1977) 0.78

Calcium-dependent oxidation of 5,8,11-icosatrienoic acid by the cyclooxygenase enzyme system. J Biol Chem (1986) 0.78

Manipulation of rat brain fatty acid composition alters volatile anesthetic potency. J Clin Invest (1986) 0.78

Effects of verapamil and trandolapril in the treatment of hypertension. Trandolapril Study Group. Am J Hypertens (1998) 0.78

Comparison of two strategies for intensifying antihypertensive treatment: low-dose combination (enalapril + felodipine ER) versus increased dose of monotherapy (enalapril). LEVEL (Lexxel vs Enalapril) Study Group. Am J Hypertens (1999) 0.78

The role of pharmacists in the detection, management, and control of hypertension: a national call to action. Pharmacotherapy (2000) 0.78

Abnormal thyroid peroxidase causing iodide organification defect. J Clin Endocrinol Metab (1972) 0.77

Use of thiazide diuretics to reduce the hypercalciuria of hypoparathyroidism during pregnancy. Am J Perinatol (1990) 0.77

Adherence to calcium channel blocker therapy in older adults: a comparison of amlodipine and felodipine. J Int Med Res (2004) 0.77

Systematic discovery and evaluation of complement inhibitors. Immunopharmacology (1981) 0.77

Rationale and design for the Controlled ONset Verapamil INvestigation of Cardiovascular Endpoints (CONVINCE) Trial. Control Clin Trials (1998) 0.77

Deficiency of superoxide dismutase in endemic goiter tissue. J Clin Endocrinol Metab (1988) 0.76

Maytansinoids. Synthesis of a fragment of known absolute configuration involving chiral centers C-6 and C-7. J Org Chem (1976) 0.76

Safety of controlled-onset extended-release verapamil in middle-aged and older patients with hypertension and coronary artery disease. Am Heart J (2001) 0.76

One-year study of felodipine or placebo for stage 1 isolated systolic hypertension. Hypertension (2001) 0.76

Which blood pressure measurement is more important in the elderly? Arch Intern Med (1999) 0.75

"Clinical pharmacology studies in patients with renal impairment: past experience and regulatory perspectives". J Clin Pharmacol (2000) 0.75

Electrocardiographic changes during acute treatment of hypertensive emergencies with sodium nitroprusside or fenoldopam. Arch Intern Med (1992) 0.75

Blood pressure and death from coronary heart disease. N Engl J Med (2000) 0.75

Chronotherapeutic delivery of verapamil in obese versus non-obese patients with essential hypertension. J Hum Hypertens (2001) 0.75

Comparison of the effects of dopamine and fenoldopam, a selective dopamine-1 agonist, on parathyroid hormone release in man. Miner Electrolyte Metab (1988) 0.75

Elevated thyroxine-binding globulin with X-chromosome linked inheritance. Clin Endocrinol (Oxf) (1979) 0.75

Stereocontrolled synthesis of alpha-multistriatin, an essential component of the aggregation pheromone for the European elm bark beetle. J Org Chem (1976) 0.75

Double-isotope derivative assay of serum iodothyronines. II. Thyroxine. Anal Biochem (1970) 0.75

Evaluation of the Suntech Accutracker. A novel noninvasive ambulatory blood pressure monitor. Am J Hypertens (1988) 0.75

Atypical adrenal insufficiency with failure of the pituitary feedback receptor. A case with associated diabetes mellitus and selective IgA deficiency with steatorrhea. Am J Med (1975) 0.75

Aldosteronism in pregnancy: association with virilization of female offspring. South Med J (1983) 0.75

Studies of thyroid hormone binding in dog brain chromatin and cytosol. Biochem Med (1979) 0.75

Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in combination: theory and practice. J Clin Hypertens (Greenwich) (2001) 0.75

Double-isotope derivative assay of serum iodothyronines. I. Preparation of acetyl derivatives of thyroxine and triiodothyronine. Anal Biochem (1970) 0.75

Double-isotope derivative assay of serum lodothyronines. 3. Triiodothyronine. Biochem Med (1973) 0.75

Low predictive value of positive Osler manoeuvre for diagnosing pseudohypertension. J Hum Hypertens (1993) 0.75

Essential fatty acid deficiency: a new look at an old problem. Prostaglandins Leukot Med (1986) 0.75

Influence of diuretic therapy on the clonidine suppression test. J Clin Pharmacol (1991) 0.75

Arachidonic acid metabolism by rabbit fetal membranes of various gestational ages. Prostaglandins (1984) 0.75

Gender and age effects on the ambulatory blood pressure and heart rate responses to antihypertensive therapy. Am J Hypertens (2001) 0.75